Predictors of Bleeding in Patients Receiving Direct Oral Anticoagulants.

Caution should be exercised when prescribing antiplatelet medications with DOACs, as this combination is a potential risk factor for both major and non-major clinically significant bleeding events. In most patients, the concurrent use of antiplatelet medications was discordant with the current consensus guidelines. This article is protected by copyright. All rights reserved.